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with the combination of ASU and EGCG (4 or 40 ng/ml) before exposure
to 300-4000 μM H2O2 signiﬁcantly inhibited PGE2 and NO production
(p<0.05). Pre-treatment with ASU and EGCG combination also signiﬁcantly
inhibited caspase 3 activity by about 50%.
Conclusions: The present study demonstrates that H2O2 induced oxidative
stress in chondrocytes can be signiﬁcantly inhibited by the combination
of ASU and EGCG. This observation indicates that the combination can
modulate the signaling pathways and cellular damage associated with
oxidative stress in chondrocytes. The ﬁnding suggests that the combination
of ASU and EGCG may be beneﬁcial for the management of joint conditions
associated with oxidative stress.
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Purpose: Because obesity is associated with osteoarthritis (OA) of non
weight-bearing joints, we have evaluated the role of visfatin, an adipose
tissue-derived hormone, to the pathophysiology of OA. We recently re-
ported on visfatin expression in articular chondrocytes and its role in
prostaglandin (PG)E2 release in cartilage. However, the signaling pathways
of visfatin remain unclear. Visfatin was ﬁrst reported as a protein that
binds to the insulin receptor (IR). More recently, a nicotinamide phospho-
ribosyltransferase (NAMPT) enzymatic activity involved in nicotinamide
mononucleotide (NMN) production, a precursor of the cofactor NAD+, has
been demonstrated. The aim of this study was to decipher the signaling
pathways implicated in visfatin induced PGE2 release in chondrocytes.
Methods: IR expression from OA human chondrocytes and immature
murine articular chondrocytes (iMACs) were assessed using real-time
RT-PCR, immunoblotting and immunocytoﬂuorescence. A highly speciﬁc
monoclonal antibody raised against IR was used. Phosphorylation of IR
and AKT was analyzed using Western Blot. IR tyrosine kinase activity
was inhibited by using HNMPA-(AM)3 and a siRNA strategy was used to
investigate the role of IR in visfatin induced PGE2 release. The role of
IGF-1 Receptor (IGF-1R) in visfatin signaling was assessed using primary
chondrocytes from IGF-1R knockout mice (IGF-1R-/-) and iMACs treated
with an IGF-1R blocking antibody. NAMPT activity was inhibted using APO
866. PGE2 was measured by EIA.
Results: (1) Visfatin is known to bind to, and to activate IR in various cell
types. However, IR is not considered to be usually present on chondrocytes.
We therefore tested the implication of IGF-1R, a close homologue to
IR, in visfatin signaling. When stimulated with 5μg/ml visfatin, IGF-1R-/-
chondrocytes unexpectedly exhibited higher PGE2 release than IGF1R+/+
controls (228±4 compared to 86±29 pg/ml, p<0.05), ruling out a direct
role of IGF-1R in the visfatin effect. Moreover, visfatin (5μg/ml - 24h)
induced PGE2 release in iMACs treated with 2 and 5μg/ml IGF-1R blocking
antibody compared to control cells (respectively a 1.3 and a 1.9 fold,
p<0.05 - visfatin treated cells released 110±16 pg/ml PGE2, n= 3). (2) IR
was expressed in cultured human chondrocytes from healthy (n=3) and OA
patients (n=7) and in iMACs (n=3). (3) Insulin (100nM - 24h) did not trigger
PGE2 release in iMACs (control: 118±68 pg/ml and insulin-stimulated cells:
130±79 pg/ml, n=3, NS). (4) Dose-responses of insulin from 0 to 1μM was
performed in term of phosphorylation of IR and Akt. Moreover, insulin
(100nM) from 0 to 60min triggered IR and Akt phosphorylation. (5) Block-
ing IR activity using HNMPA-(AM)3 (100nM - 24h pre-treatment) inhibited
visfatin (5μg/ml - 24 h) induced PGE2 release (54% decrease, n=3, p<0.05).
Moreover, blocking IR expression by siRNA inhibited visfatin-induced PGE2
release (5μg/ml visfatin: 3576±265 pg/ml versus visfatin + IR siRNA1:
1864±515 pg/ml and visfatin + IR siRNA2: 930±216 pg/ml corresponding
to a 48% and 74% decrease respectively, n=2, p<0.05). (6) Inhibition of the
NAMPT activity of visfatin using APO866 from 0 to 1μM gradually induced
a decrease in PGE2 release up to 32% (visfatin treated cells released 95±30
pg/ml PGE2,n=3, p<0.05).
Conclusions: In chondrocytes, visfatin exerts pro-inﬂammatory events by
both activation of its cognate receptor and Nampt activity.
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Purpose: In knee joints with OA, ﬁbrosis is a major contributor to both joint
pain and stiffness. We found that TGF-β overexpression in murine knee
joints leads to persistent ﬁbrosis of the joint capsule while overexpression
of CTGF, induced transient ﬁbrosis. Strikingly, TGF-β overexpression gave
a major increase in lysyl hydroyxylase 2b (LH2b) expression, whereas
CTGF did not change LH2b gene expression. It has been shown that
hydroxylysine-derived cross links, formed by LH2b, are much more resis-
tant to degradation than lysine-associated cross links. Therefore a causal
relationship between LH2b and irreversible ﬁbrosis after TGF-β exposure is
plausible.
We investigated whether TGF-β can also induce LH2b in human synovial
ﬁbroblasts similar to our ﬁndings in mice. In addition we investigated
which TGF-β route ALK1 (Smad1/5/8) or ALK5 (Smad2/3) is responsible for
LH2b regulation in human ﬁbroblasts.
Methods: Human synovial ﬁbroblasts were isolated from OA synovial tis-
sue, obtained from knee joint arthroplasties. Primary cell cultures derived
from ﬁve different donors were used to carry out the experiments. The
ﬁbroblasts were stimulated with TGF-β to determine the effects on LH1,
LH2b, LH3, lysyl oxidase (LOX), collagen type 1A1 (COL 1A1), and CTGF gene
expression. After 24h incubation with TGF-β, RNA was isolated and the
gene expression was analyzed with RT-PCR. To examine the effect of ALK1
(Smad1/5/8) and ALK5 (Smad2/3) signaling on gene expression separately,
we used SB-505124 (SB5) and dorsomorphin (DM) to block Smad2/3 and
Smad1/5/8 phosphorylation respectively. Changes in Smad 2/3 and Smad
1/5/8 phosphorylation were determined with Western Blotting.
Results: Western Blotting showed that the increase of Smad2P as a result of
TGF-β exposure is completely blocked by SB-5 and not by DM. Smad1/5/8
phosphorylation was inhibited by DM whereas SB-5 did not inﬂuence
Smad1/5/8P levels. TGF-β stimulation induced LH2b, CTGF, COL1A1 and
Figure 1. Relative RNA expression of LH 1, 2b and 3 in human synovial ﬁbroblasts after 24
h TGF-β stimulation. Error bars represent 95% CI.
Figure 2. Relative RNA expression of LH 1, 2b and 3 in human synovialﬁbroblasts after 4 h
pre-incubation with SB/DM prior to 24 h TGF-β stimulation. Error bars represent 95% CI.
